FINANCIALS

BMRN Biomarin Pharmaceutical Inc 1048477

Income Statement
Revenue	bmrn-20241231	2,853,915,000
Net Income	bmrn-20241231	426,859,000
Profit Margin		14.96%

Balance Sheet
Current Assets	3,232,427,000
Assets	6,988,940,000
Current Liabilities	606,988,000
Liabilities	1,330,950,000
Equity	5,657,990,000
Shares Out	190,383,000

Cash Flow Statement
Operating Cash Flow	572,841,000
Investing Cash Flow	136,491,000

Market Analysis
Market Cap	13,437,218,372
Price	71.38
BVPS	29.72
PB	2.40
EPS	1.33
PE	53.21
PS	1.18
FCF	709,332,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view BMRN documents filed with the SEC.

BMRN Filings Clear

View A List of Tickers